ORGANO CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8,300 JPY | +1.72% |
|
-6.11% | +42.12% |
| Sales 2025 * | 157B 1B | Sales 2026 * | 166B 1.06B | Capitalization | 381B 2.43B |
|---|---|---|---|---|---|
| Net income 2025 * | 17.17B 109M | Net income 2026 * | 18.6B 119M | EV / Sales 2025 * | 2.43 x |
| Net cash position 2025 * | - 0 | Net cash position 2026 * | - 0 | EV / Sales 2026 * | 2.3 x |
| P/E ratio 2025 * |
22.2
x | P/E ratio 2026 * |
20.5
x | Employees | 2,512 |
| Yield 2025 * |
1.25% | Yield 2026 * |
1.4% | Free-Float | 53.69% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +1.72% | ||
| 1 week | -6.11% | ||
| Current month | -5.79% | ||
| 1 month | -2.35% | ||
| 3 months | +9.79% | ||
| 6 months | +52.29% | ||
| Current year | +42.12% |
1 week
8 050.00
8 810.00
1 month
7 850.008 860.00
Current year
5 520.008 860.00
1 year
3 625.008 860.00
3 years
1 457.508 860.00
5 years
845.008 860.00
10 years
471.258 860.00
| Managers | Title | Age | Since |
|---|---|---|---|
Masayuki Yamada
PSD | President | 65 | 19-05-31 |
Masaki Uchikura
CHM | Chairman | 69 | 17-06-28 |
Nobuyoshi Suda
CTO | Chief Tech/Sci/R&D Officer | 60 | 84-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Motoo Nagai
BRD | Director/Board Member | 70 | 14-05-31 |
Masaki Uchikura
CHM | Chairman | 69 | 17-06-28 |
Masahiko Toyoda
AUD | Comptroller/Controller/Auditor | 68 | 12-05-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.99% | 4 M€ | +10.47% | - | |
| 0.28% | 10 M€ | +23.07% | ||
| 0.02% | 138,841 M€ | +18.91% | ||
| 0.02% | 19,753 M€ | +17.73% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-10 | 8,300 | +1.72% | 176 500 |
| 24-06-07 | 8,160 | 0.00% | 174,000 |
| 24-06-06 | 8,160 | +0.37% | 233,300 |
| 24-06-05 | 8,130 | -2.75% | 318,600 |
| 24-06-04 | 8,360 | -5.43% | 409,200 |
Delayed Quote Japan Exchange, June 10, 2024 at 02:00 am EDT
More quotes
ORGANO CORPORATION is a Japan-based company mainly engaged in the water treatment engineering business and functional products business. The Company operates through two business segments. The Water Treatment Engineering segment is mainly engaged in the manufacture, sale, maintenance and management of filtration equipment, pure water system equipment and other water treatment related equipment. The Functional Product segment is mainly engaged in the manufacture and sale of standard water treatment equipment, water treatment chemicals and food additives. The Company is also engaged in the chemical plant construction business.
Calendar
2024-07-30
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
8,160
JPY
Average target price
8,000
JPY
Spread / Average Target
-1.96%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +42.12% | 2.39B | |
| +11.83% | 8.81B | |
| -12.72% | 1.08B | |
| +14.00% | 816M | |
| +26.46% | 758M | |
| -6.31% | 738M | |
| -8.47% | 586M | |
| -21.85% | 551M | |
| -19.03% | 490M | |
| -2.26% | 486M |
- Stock Market
- Equities
- 6368 Stock
